PCN69 Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab (MabThera) for Non-Hodgkins Lymphoma Patients in Greece, a Local Adaptation
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2109
https://www.valueinhealthjournal.com/article/S1098-3015(12)03823-5/fulltext
Title :
PCN69 Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab (MabThera) for Non-Hodgkins Lymphoma Patients in Greece, a Local Adaptation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03823-5&doi=10.1016/j.jval.2012.08.2109
First page :
A421
Section Title :
Cancer
Open access? :
No
Section Order :
761